gip/glp-1 ra GIPR/GLP-1R dual agonist therapies for diabetes and weight loss– Chemistry, Physiology and Clinical application The Effects of Dual GLP-1/GIP

Butz F, Aita H, Wang CJ, Ogawa T

The medication has been studied most prominently for managing blood sugar in patients with Type 2 diabetes, meaning some providers may only prescribe it for people with diabetes

Brill AL, Wisinski JA, Cadena MT, Thompson MF, Fenske RJ, Brar HK, et al

A decrease in body weight, blood pressure, HbA1c, fasting insulin, insulin resistance, plasma glucagon, total cholesterol, lipids, FPG, SMBG, cardiovascular death, nonfatal stroke, and myocardial infarction are observed with the use of semaglutide in monotherapy or in combination with other antidiabetic drugs

Patients can inject them by themselves in specific body areas